Institute for Wealth Management’s AnaptysBio ANAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-8,055
Closed -$250K 450
2022
Q4
$250K Sell
8,055
-3,492
-30% -$98.6K 0.05% 384
2022
Q3
$295K Hold
11,547
0.07% 341
2022
Q2
$234K Buy
11,547
+3,432
+42% +$76K 0.05% 457
2022
Q1
$201K Hold
8,115
0.03% 514
2021
Q4
$282K Sell
8,115
-3,750
-32% -$119K 0.05% 392
2021
Q3
$322K Hold
11,865
0.06% 353
2021
Q2
$308K Hold
11,865
0.05% 368
2021
Q1
$256K Buy
+11,865
New +$299K 0.05% 394

Other funds holding ANAB

Institute for Wealth Management's ANAB Position: Q1 2023 in Review

Institute for Wealth Management sold out of AnaptysBio (ANAB) in Q1 2023, closing a stake of 8,055 shares — an estimated $250K sold.

Institute for Wealth Management first reported a position in ANAB in Q1 2021 and held it in 8 quarters. The position peaked at $322K in Q3 2021. 113 funds tracked by Wall St. Rank hold ANAB as of Q1 2023.

  • Institute for Wealth Management reported no remaining AnaptysBio position as of Q1 2023 after selling out during the quarter.
  • Institute for Wealth Management sold 8,055 AnaptysBio shares in Q1 2023, an estimated $250K.
  • Institute for Wealth Management first reported a position in AnaptysBio in Q1 2021 and held it in 8 quarters.
  • Institute for Wealth Management's AnaptysBio position peaked at $322K in Q3 2021.
  • 113 funds tracked by Wall St. Rank held AnaptysBio as of Q1 2023.

Based on Institute for Wealth Management's 13F filing for Q1 2023, filed 20 Apr 2023.